Exane Derivatives’s Kohl's KSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-14
Closed -$846 869
2022
Q1
$846 Hold
14
﹤0.01% 817
2021
Q4
$691 Buy
+14
New +$715 ﹤0.01% 740
2020
Q2
Sell
-50,756
Closed -$741K 725
2020
Q1
$741K Sell
50,756
-5,452
-10% -$204K 0.21% 96
2019
Q4
$2.63M Buy
56,208
+25,522
+83% +$1.3M 0.49% 66
2019
Q3
$1.52M Sell
30,686
-100,460
-77% -$4.93M 0.27% 81
2019
Q2
$6.23M Buy
131,146
+85,922
+190% +$5.18M 1.09% 17
2019
Q1
$3.11M Sell
45,224
-627
-1% -$42.5K 0.61% 55
2018
Q4
$3.04M Buy
45,851
+38,742
+545% +$2.72M 0.55% 57
2018
Q3
$530K Sell
7,109
-23,796
-77% -$1.8M 0.1% 156
2018
Q2
$2.25M Sell
30,905
-3,952
-11% -$263K 0.38% 62
2018
Q1
$2.25M Buy
34,857
+18,991
+120% +$1.21M 0.45% 47
2017
Q4
$860K Buy
15,866
+13,700
+633% +$631K 0.15% 109
2017
Q3
$98.9K Sell
2,166
-1,521
-41% -$62.4K 0.02% 261
2017
Q2
$143K Buy
3,687
+2,497
+210% +$95.7K 0.03% 231
2017
Q1
$47.4K Buy
+1,190
New +$48.6K 0.01% 270

Other funds holding KSS

Exane Derivatives's KSS Position: Q2 2022 in Review

Exane Derivatives sold out of Kohl's (KSS) in Q2 2022, closing a stake of 14 shares — an estimated $846 sold.

Exane Derivatives first reported a position in KSS in Q1 2017 and held it in 15 quarters. The position peaked at $6.23M in Q2 2019. 440 funds tracked by Wall St. Rank hold KSS as of Q2 2022.

  • Exane Derivatives reported no remaining Kohl's position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 14 Kohl's shares in Q2 2022, an estimated $846.
  • Exane Derivatives first reported a position in Kohl's in Q1 2017 and held it in 15 quarters.
  • Exane Derivatives's Kohl's position peaked at $6.23M in Q2 2019.
  • 440 funds tracked by Wall St. Rank held Kohl's as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.